Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Wendy B. London"'
Autor:
Daria Thompson, Kieuhoa T. Vo, Wendy B. London, Garrett M. Brodeur, Peter F. Ambros, Matthias Fischer, Akira Nakagawara, Katherine K. Matthay, Steven G. DuBois
Publikováno v:
Cancer. 122:935-945
BACKGROUND MYCN gene amplification (MNA) is a hallmark of aggressive neuroblastoma. This study was performed to determine univariate and multivariate predictors of tumor MNA. METHODS Data from the International Neuroblastoma Risk Group were analyzed
Autor:
Kevin, Campbell, Julie M, Gastier-Foster, Meegan, Mann, Arlene H, Naranjo, Collin, Van Ryn, Rochelle, Bagatell, Katherine K, Matthay, Wendy B, London, Meredith S, Irwin, Hiroyuki, Shimada, M Meaghan, Granger, Michael D, Hogarty, Julie R, Park, Steven G, DuBois
Publikováno v:
Cancer. 123(21)
High-level MYCN amplification (MNA) is associated with poor outcome and unfavorable clinical and biological features in patients with neuroblastoma. To the authors' knowledge, less is known regarding these associations in patients with low-level MYCN
Autor:
Robert C. Seeger, Xao X. Tang, Susan L. Cohn, Hiroyuki Shimada, John M. Maris, Wendy B. London, Rie Suganuma, Patrick McGrady, Naohiko Ikegaki, Larry Wang, Arlene Naranjo, A. Thomas Look, Michael D. Hogarty, Julie R Park, Julie M. Gastier-Foster
Publikováno v:
Cancer. 119:3718-3726
BACKGROUND This study sought to investigate biological/clinicopathological characteristics of neuroblastoma, undifferentiated subtype (NBUD). METHODS This study examined 157 NBUD cases filed at the Children's Oncology Group Neuroblastoma Pathology Re
Autor:
Zhengjia Chen, Marleta Reynolds, Wendy B. London, Jon M. Rowland, Marcio H. Malogolowkin, Milton J. Finegold, Kay W. Chang, Mark Krailo, Alberto S. Pappo, Howard M. Katzenstein
Publikováno v:
Cancer. 115:5828-5835
BACKGROUND: The current study was conducted to determine whether amifostine is effective in reducing the toxicities associated with the administration of platinum-containing regimens in children with hepatoblastoma (HB). METHODS: Patients were enroll
Autor:
Wendy B. London, Carlos Rodriguez-Galindo, James Fontanesi, Gregory P. Swanson, Marcia M. Wofford, Robert P. Castleberry, Alberto S. Pappo, Edwin C. Douglass
Publikováno v:
Cancer. 103:850-857
BACKGROUND Nasopharyngeal carcinoma (NPC) is rare in children, accounting for < 1% of all cases. Treatment most commonly includes radiotherapy but long-term side effects of such treatment can produce devastating cosmetic and functional sequelae in ch
Autor:
Mitchell Ryan, Leigh Ann Cahill, Janet F. Stastny, Rebecca E. Remmers, Mary Ann Pedigo, William J. Frable, Wendy B. London
Publikováno v:
Cancer. 81:348-353
BACKGROUND There is an increasing number of articles regarding the long term follow-up of Papanicolaou (Pap) smears with the diagnosis of atypical squamous cells of undetermined significance (ASCUS). Much controversy exists regarding the management o
Autor:
Larry L, Wang, Rie, Suganuma, Naohiko, Ikegaki, Xao, Tang, Arlene, Naranjo, Patrick, McGrady, Wendy B, London, Michael D, Hogarty, Julie M, Gastier-Foster, A Thomas, Look, Julie R, Park, John M, Maris, Susan L, Cohn, Robert C, Seeger, Hiroyuki, Shimada
Publikováno v:
Cancer. 119(20)
This study sought to investigate biological/clinicopathological characteristics of neuroblastoma, undifferentiated subtype (NBUD).This study examined 157 NBUD cases filed at the Children's Oncology Group Neuroblastoma Pathology Reference Laboratory,
Autor:
María Ah-Chu-Sanchez, Ingrid Carolina Arambú, Wendy B. London, Federico Antillon-Klussmann, Carlos Rodriguez-Galindo, Paola Friedrich, Fulgencio Baez, Roberta Ortiz, Soad Fuentes, Yessica Gamboa, Kelly Strait
Publikováno v:
Cancer. 119(4)
BACKGROUND: Children with cancer in middle-income countries have inferior outcomes compared with similar children in high-income countries. The magnitude and drivers of this survival gap are not well understood. In the current report, the authors sou
Autor:
Mary Davis, Thomas A. Olson, A. Lindsay Frazier, Richard B. Womer, Frederick Rescorla, Neyssa Marina, Stephen J. Lauer, Kay W. Chang, Wendy B. London, Marcio Malogolowkin, Roger Giller, Deborah F. Billmire, Elizabeth J. Perlman
Publikováno v:
Cancer. 104(4)
BACKGROUND High-dose cisplatin combined with etoposide and bleomycin (HDPEB) improves event-free survival (EFS) in advanced pediatric germ-cell tumors (PGCT), but has significant ototoxicity. Amifostine appears to protect against toxicity. The author
Autor:
Carlos, Rodriguez-Galindo, Marcia, Wofford, Robert P, Castleberry, Gregory P, Swanson, Wendy B, London, James, Fontanesi, Alberto S, Pappo, Edwin C, Douglass
Publikováno v:
Cancer. 103(4)
Nasopharyngeal carcinoma (NPC) is rare in children, accounting for1% of all cases. Treatment most commonly includes radiotherapy but long-term side effects of such treatment can produce devastating cosmetic and functional sequelae in children. Chemot